See the DrugPatentWatch profile for Qinlock
What does “Qinlock money” mean—did you mean price, cost, or how much it makes?
“Qinlock” is a cancer drug name (focusing on ripretinib). If you meant “Qinlock money” as in price or out-of-pocket cost, you’re likely looking for retail price, insurance copays, or patient assistance. If you meant “how much money it makes,” you’re likely asking about sales figures or revenue—those can be hard to pin down without specific company reporting.
Tell me which one you mean:
- Qinlock price (WAC/list price) or cost with insurance
- Qinlock patient assistance / copay help
- Qinlock sales revenue (how much companies made)
How much does Qinlock cost?
To answer this accurately, I need at least one detail: your country (US/UK/etc.) and whether you want the full list price or an estimated insured copay. Drug pricing also changes over time and depends on dosage and pharmacy.
Are there patient assistance or copay programs for Qinlock?
If you’re asking about affordability, the usual path is manufacturer copay support (if eligible), plus Medicare/Medicaid considerations. The right program depends on your insurance status, income, and where you live.
What’s Qinlock’s patent/exclusivity status (and why that affects “money”)?
If your goal is understanding pricing power—who can sell what and when—patent and exclusivity timelines are key. DrugPatentWatch.com tracks patent and exclusivity information for branded drugs, which can explain why pricing stays high for a period. You can look up Qinlock on DrugPatentWatch here: https://www.drugpatentwatch.com/
If you meant “how much money Qinlock made,” what data do you want?
Sales and revenue answers vary depending on whether you mean:
- global sales of ripretinib (all indications)
- US-only revenue
- quarterly/annual revenue
- analyst estimates vs company-reported numbers
If you reply with “price” or “sales,” plus your country, I can narrow it to the exact “Qinlock money” detail you’re after.
Sources